Related Experiment Video
Updated: Apr 3, 2026

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma
Ana Ortega-Molina1, Isaac W Boss2,3, Andres Canela4
1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.
Abstract:
The gene encoding the lysine-specific histone methyltransferase KMT2D has emerged as one of the most frequently mutated genes in follicular lymphoma and diffuse large B cell lymphoma; however, the biological consequences of KMT2D mutations on lymphoma development are not known. Here we show that KMT2D functions as a bona fide tumor suppressor and that its genetic ablation in B cells promotes lymphoma development in mice. KMT2D deficiency also delays germinal center involution and impedes B cell differentiation and class switch recombination. Integrative genomic analyses indicate that KMT2D affects methylation of lysine 4 on histone H3 (H3K4) and expression of a set of genes, including those in the CD40, JAK-STAT, Toll-like receptor and B cell receptor signaling pathways. Notably, other KMT2D target genes include frequently mutated tumor suppressor genes such as TNFAIP3, SOCS3 and TNFRSF14. Therefore, KMT2D mutations may promote malignant outgrowth by perturbing the expression of tumor suppressor genes that control B cell-activating pathways.
Insights
The gene KMT2D acts as a tumor suppressor in B cell lymphomas. Its loss promotes lymphoma development by disrupting key signaling pathways and tumor suppressor gene expression.
Area of Science:
- Hematology
- Oncology
- Epigenetics
Background:
- The gene KMT2D is frequently mutated in follicular lymphoma and diffuse large B cell lymphoma.
- The biological role of KMT2D mutations in lymphoma pathogenesis remains unclear.
Purpose of the Study:
- To investigate the function of KMT2D in B cell lymphoma development.
- To elucidate the molecular mechanisms by which KMT2D mutations contribute to lymphomagenesis.
Main Methods:
- Genetic ablation of KMT2D in mouse B cells.
- Analysis of lymphoma development and B cell differentiation.
- Integrative genomic analyses of histone methylation and gene expression.
Main Results:
- KMT2D functions as a tumor suppressor, and its genetic ablation promotes lymphoma development in mice.
- KMT2D deficiency impairs germinal center involution, B cell differentiation, and class switch recombination.
- KMT2D regulates H3K4 methylation and the expression of genes in critical B cell signaling pathways (CD40, JAK-STAT, TLR, BCR).
- KMT2D targets other tumor suppressor genes (TNFAIP3, SOCS3, TNFRSF14) frequently mutated in lymphoma.
Conclusions:
- KMT2D is a critical tumor suppressor in B cell lymphomas.
- KMT2D mutations may drive malignant outgrowth by altering the expression of tumor suppressor genes involved in B cell signaling.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
10:26In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Related Concept Videos
Abnormal Proliferation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Spreading of Chromatin Modifications
Writers
The writer...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Methods of Nuclear Reprogramming